{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:29:55Z","timestamp":1792801795917,"version":"4.5.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","license":[{"start":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T00:00:00Z","timestamp":1663113600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Endoscopic retrograde cholangiopancreatography (ERCP) is the endoscopic modality of choice for the treatment of biliary and pancreatic diseases. However, patients with cirrhosis, particularly those with decompensated cirrhosis, are believed to be at increased risk for complications associated with ERCP. There is a paucity of literature describing the outcomes of ERCP for patients with cirrhosis. This study aimed to investigate the outcomes of ERCP for cirrhosis patients, especially adverse events, and evaluated its safety and efficacy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We performed a multicenter, retrospective study of all patients at Beijing Friendship Hospital affiliated to Capital Medical University, Xijing Hospital affiliated to Air Force Military Medical University, Beijing Youan Hospital affiliated to Capital Medical University, and the Fifth Medical Center of the People's Liberation Army General Hospital from June 2003 to August 2019. The adverse events of inpatient ERCP for patients with (<jats:italic toggle=\"yes\">n<\/jats:italic>\u200a=\u200a182) and without liver cirrhosis (controls; <jats:italic toggle=\"yes\">n<\/jats:italic>\u200a=\u200a385) were compared.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 567 patients underwent ERCP between January 2003 and December 2019 were enrolled in this study. Compared to patients without cirrhosis, patients with cirrhosis were at higher risk for postoperative complications (odds ratio [OR], 4.172; 95% confidence interval [CI], 1.232\u20137.031; <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a0.001) such as postoperative pancreatitis (OR, 2.026; 95% CI, 1.002\u20134.378; <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.001) and cholangitis (OR, 3.903; 95% CI, 1.001\u201310.038; <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.036). The main indications for ERCP for patients with cirrhosis in this study included choledocholithiasis (101 cases; 55.5%), benign bile duct strictures (46 cases; 25.3%), and malignant bile duct strictures (28 cases; 15.4%). Among them, 23 patients (12.6%) underwent balloon dilation and 79 patients (43.4%) underwent sphincterotomy. Of the patients with cirrhosis, delayed bleeding occurred in ten patients (5.5%), postoperative pancreatitis occurred in 80 patients (44.0%), and postoperative cholangitis occurred in 25 patients (13.7%). An additional multivariate analysis showed that the total bilirubin (TBIL) level (OR, 4.58; 95% CI, 2.37\u20136.70) and Child-Pugh score of C (OR, 3.11; 95% CI, 1.04\u20135.37) were risk factors for postoperative complications in patients with cirrhosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Compared with the general population of patients undergoing ERCP, patients with cirrhosis were more prone to postoperative pancreatitis and cholangitis. TBIL levels and Child-Pugh scores were risk factors for postoperative complications in patients with cirrhosis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cm9.0000000000002248","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:01:49Z","timestamp":1663200109000},"page":"2319-2325","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Analysis of risk factors associated with endoscopic retrograde cholangiopancreatography for patients with liver cirrhosis: a multicenter, retrospective, clinical study"],"prefix":"10.1097","volume":"135","author":[{"given":"Jielin","family":"Li","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Disease, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiexuan","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Oncology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Disease, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongdong","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Disease, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Disease, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Disease, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Hua","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Cheng De Central Hospital, Chengde, Hebei 067000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Ran","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Third People's Hospital of Chengdu, Chengdu, Sichuan 610031, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanglin","family":"Pan","sequence":"additional","affiliation":[{"name":"Xijing Hospital of Digestive Diseases, Air Force Medical University of People's Liberation Army, Xi\u2019an, Shaanxi 710032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shutian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Disease, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,10,5]]},"reference":[{"key":"R1-20250603","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.gie.2015.08.022","article-title":"Efficacy and safety of therapeutic ERCP in patients with cirrhosis: a large multicenter study","volume":"83","author":"Adler","year":"2016","journal-title":"Gastrointest Endosc"},{"key":"R2-20250603","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.gie.2016.06.051","article-title":"Adverse events associated with ERCP","volume":"85","author":"Chandrasekhara","year":"2017","journal-title":"Gastrointest Endosc"},{"key":"R3-20250603","doi-asserted-by":"crossref","first-page":"523","DOI":"10.4253\/wjge.v11.i11.523","article-title":"Evaluating the risk of adverse events with interventional endoscopic retrograde cholangiopancreatography and endoscopic ultrasound procedures in cirrhotic patients","volume":"11","author":"Yoo","year":"2019","journal-title":"World J Gastrointest Endosc"},{"key":"R4-20250603","doi-asserted-by":"crossref","first-page":"7277","DOI":"10.3748\/wjg.v20.i23.7277","article-title":"Gallstones in patients with liver cirrhosis: incidence, etiology, clinical and therapeutical aspects","volume":"20","author":"Acalovschi","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R5-20250603","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jceh.2019.01.006","article-title":"Is it safe to perform endoscopic retrograde cholangiopancreatography in decompensated cirrhosis?","volume":"9","author":"Jagtap","year":"2019","journal-title":"J Clin Exp Hepatol"},{"key":"R6-20250603","doi-asserted-by":"crossref","first-page":"S429","DOI":"10.1038\/ajg.2017.304","article-title":"A randomized trial of rectal indomethacin and papillary spray of epinephrine versus rectal indomethacin alone for the prevention of post-ERCP pancreatitis in high-risk patients: 2017 category award (Interventional Endoscopy): 769","volume":"112","author":"Kamal","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"R7-20250603","doi-asserted-by":"crossref","first-page":"E303","DOI":"10.1055\/s-0043-102492","article-title":"Safety of ERCP in patients with liver cirrhosis: a national database study","volume":"5","author":"Navaneethan","year":"2017","journal-title":"Endosc Int Open"},{"key":"R8-20250603","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s11596-014-1325-x","article-title":"Safety and efficacy of endoscopic retrograde cholangiopancreatography for common bile duct stones in liver cirrhotic patients","volume":"34","author":"Li","year":"2014","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"R9-20250603","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00464-018-6290-1","article-title":"National trends of endoscopic retrograde cholangiopancreatography utilization and outcomes in decompensated cirrhosis","volume":"33","author":"Mehta","year":"2019","journal-title":"Surg Endosc"},{"key":"R10-20250603","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41395-018-0271-9","article-title":"ERCP in patients with cirrhosis: \u201cRisky business\u201d or \u201cjust do it\u201d?","volume":"114","author":"Shah","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"R11-20250603","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1097\/CM9.0000000000001084","article-title":"Management of chronic liver diseases and cirrhosis: current status and future directions","volume":"133","author":"Xu","year":"2020","journal-title":"Chin Med J"},{"key":"R12-20250603","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1572-0241.2001.03594.x","article-title":"Complications of diagnostic and therapeutic ERCP: a prospective multicenter study","volume":"96","author":"Masci","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R13-20250603","first-page":"1712","article-title":"Current situation of endoscopic treatment for common bile duct stones","volume":"59","author":"Sakai","year":"2012","journal-title":"Hepatogastroenterology"},{"key":"R14-20250603","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-230X-13-66","article-title":"Liver disease and 30-day mortality after colorectal cancer surgery: a Danish population-based cohort study","volume":"13","author":"Montomoli","year":"2013","journal-title":"BMC Gastroenterol"},{"key":"R15-20250603","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.3748\/wjg.v22.i11.3196","article-title":"Predictors of re-bleeding after endoscopic hemostasis for delayed post-endoscopic Sphincterotomy bleeding","volume":"22","author":"Lee","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"(3)","key":"R16-20250603","doi-asserted-by":"crossref","first-page":"e433","DOI":"10.1097\/MD.0000000000000433","article-title":"MELD scores and Child-Pugh classifications predict the outcomes of ERCP in cirrhotic patients with choledocholithiasis: a retrospective cohort study","volume":"94","author":"Zhang","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"R17-20250603","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1055\/s-0034-1377875","article-title":"Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) guideline-updated June 2014","volume":"46","author":"Dumonceau","year":"2014","journal-title":"Endoscopy"},{"key":"R18-20250603","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/liv.13100","article-title":"Decompensated cirrhosis may be a risk factor for adverse events in endoscopic retrograde cholangiopancreatography","volume":"36","author":"Inamdar","year":"2016","journal-title":"Liver Int"},{"key":"R19-20250603","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/hep.24616","article-title":"Burden of cirrhosis on older Americans and their families: analysis of the health and retirement study","volume":"55","author":"Rakoski","year":"2012","journal-title":"Hepatology"},{"key":"R20-20250603","doi-asserted-by":"crossref","first-page":"354","DOI":"10.4253\/wjge.v10.i11.354","article-title":"Endoscopic retrograde cholangiopancreatography in cirrhosis - a systematic review and meta-analysis focused on adverse events","volume":"10","author":"Mashiana","year":"2018","journal-title":"World J Gastrointest Endosc"},{"key":"R21-20250603","doi-asserted-by":"crossref","first-page":"599","DOI":"10.5009\/gnl20171","article-title":"Direct bilirubin is more valuable than total bilirubin for predicting prognosis in patients with liver cirrhosis","volume":"15","author":"Lee","year":"2021","journal-title":"Gut Liver"},{"key":"R22-20250603","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/1751-2980.12661","article-title":"Outcome of endoscopic retrograde cholangiopancreatography in patients with clinically defined decompensated liver cirrhosis","volume":"19","author":"Lee","year":"2018","journal-title":"J Dig Dis"},{"key":"R23-20250603","first-page":"485","article-title":"Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography","volume":"3","author":"Syr\u00e9n","year":"2019","journal-title":"BJS Open"},{"key":"R24-20250603","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/MEG.0000000000000768","article-title":"Risk factors associated with complications in cirrhotic patients undergoing endoscopic retrograde cholangio-pancreatography","volume":"29","author":"Mac\u00edas-Rodr\u00edguez","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R25-20250603","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1097\/CM9.0000000000000835","article-title":"Regression of liver fibrosis: evidence and challenges","volume":"133","author":"Sun","year":"2020","journal-title":"Chin Med J"},{"key":"R26-20250603","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41395-018-0218-1","article-title":"Adverse events and acute chronic liver failure in patients with cirrhosis undergoing endoscopic retrograde cholangiopancreatography: a multicenter matched-cohort study","volume":"114","author":"Leal","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"R27-20250603","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1097\/MPA.0b013e31827e95e9","article-title":"Risk models for post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP): smoking and chronic liver disease are predictors of protection against PEP","volume":"42","author":"DiMagno","year":"2013","journal-title":"Pancreas"},{"key":"R28-20250603","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3349\/ymj.2019.60.5.440","article-title":"Bleeding complications and clinical safety of endoscopic retrograde cholangiopancreatography in patients with liver cirrhosis","volume":"60","author":"Kim","year":"2019","journal-title":"Yonsei Med J"},{"key":"R29-20250603","doi-asserted-by":"crossref","first-page":"472","DOI":"10.4254\/wjh.v13.i4.472","article-title":"Retrospective analysis of complications related to endoscopic retrograde cholangio-pancreatography in patients with cirrhosis vs. patients without cirrhosis","volume":"13","author":"Bernshteyn","year":"2021","journal-title":"World J Hepatol"},{"key":"R30-20250603","first-page":"772","article-title":"Chinese guidelines for ERCP (2018) (in Chinese)","volume":"57","year":"2018","journal-title":"Chin J Intern Med"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000002248","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T19:00:13Z","timestamp":1748977213000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000002248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,14]]},"references-count":30,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000002248","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,14]]}}}